Asunto(s)
Aborto Incompleto , Aborto Espontáneo , Infecciones Bacterianas/diagnóstico , Recolección de Datos/normas , Endometritis/microbiología , Inmunización/efectos adversos , Endometritis/diagnóstico , Femenino , Humanos , Inmunización/estadística & datos numéricos , Salud Materna , Periodo Posparto , Guías de Práctica Clínica como Asunto , EmbarazoRESUMEN
The influence of the diet on the quality of buffalo (Bubalus bubalis) carcasses of crossbred Murrah and Mediterranean, concentrate fed on traditional (corn/soybean) or on agro-industrial residues (palm oil and coconut cakes) was studied. The animals were sacrificed in a slaughterhouse, and physical and physical-chemical analyses in the carcasses were carried out after 24 hours, and instrumental color and texture analyses of the Longissimus dorsi were carried out 48 hours after cooling. The animals supplemented with palm oil cake had better carcass conformation and fat trim, and differences (P<0.05) in the percentage of fat in the carcass fat thickness and coverage were observed.
Avaliou-se a influência da dieta sobre a qualidade de carcaça de búfalos mestiços das raças Murrah e Mediterrâneo, alimentados com concentrado tradicional - milho/soja - ou resíduos agroindustriais - tortas de coco e dendê. Os animais foram sacrificados em abatedouro comercial, e realizadas análises físicas e físico-químicas na carcaça, após 24 horas, e de cor e textura instrumentais no músculo Longissimus dorsi, após 48 horas de resfriamento. Os animais suplementados com a torta de dendê adquiriram melhor conformação de carcaça e acabamento de gordura, e observaram-se diferenças (P<0,05) no percentual de gordura na carcaça e na espessura de gordura de cobertura.
Asunto(s)
Animales , Búfalos/fisiología , Composición de AlimentosRESUMEN
The objective of this Phase 4, open-label, multicentre, observational study was to fulfil food and drug administration (FDA) postapproval requirement to evaluate in healthcare practices the risk of insulin-induced severe hypoglycaemia following initiation of pramlintide therapy in N = 1297 patients with type 1 diabetes mellitus (T1DM) and type 2 diabetes mellitus (T2DM) with inadequate glycaemic control. The duration of the study was approximately 6 months. During the adjustment period (0-3 months), the incidence and event rate of patient-ascertained severe hypoglycaemia (PASH) were 4.8% and 0.33 events/patient-year in patients with T1DM and 2.8% and 0.19 events/patient-year in patients with T2DM. During the maintenance period (>3-6 months), the incidence and event rate of PASH declined in patients with T1DM or T2DM. This study confirms that in healthcare practices, the risk of insulin-induced severe hypoglycaemia following the initiation of pramlintide is low in patients with T1DM or T2DM.
